Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Ipsen,Lanreotide acetate,"Gastroenteropancreatic neuroendocrine tumours, non-functional",Lanreotide acetate (somatuline autogel),Options for investment,,Oncology Agents and Immunosuppressants
